Cellebrite DI (NASDAQ:CLBT) — Market Cap & Net Worth
Market Cap & Net Worth: Cellebrite DI (CLBT)
Cellebrite DI (NASDAQ:CLBT) has a market capitalization of $3.10 Billion ($3.10 Billion) as of May 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #4834 globally and #1555 in its home market, demonstrating a 4.87% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cellebrite DI's stock price $13.35 by its total outstanding shares 249439817 (249.44 Million). Analyse Cellebrite DI (CLBT) cash flow conversion to see how efficiently the company converts income to cash.
Cellebrite DI Market Cap History: 2020 to 2026
Cellebrite DI's market capitalization history from 2020 to 2026. Data shows growth from $2.63 Billion to $3.33 Billion (6.08% CAGR).
Index Memberships
Cellebrite DI is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.01% | #526 of 3165 |
Weight: Cellebrite DI's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Cellebrite DI Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cellebrite DI's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
9.45x
Cellebrite DI's market cap is 9.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
57.42x
Cellebrite DI's market cap is 57.42 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.63 Billion | $194.91 Million | $5.78 Million | 13.48x | 454.35x |
| 2021 | $2.00 Billion | $246.25 Million | $71.40 Million | 8.12x | 28.02x |
| 2022 | $1.09 Billion | $270.65 Million | $120.81 Million | 4.02x | 9.00x |
| 2023 | $2.16 Billion | $325.11 Million | -$81.10 Million | 6.64x | N/A |
| 2024 | $5.50 Billion | $401.20 Million | -$283.01 Million | 13.70x | N/A |
| 2025 | $4.50 Billion | $475.68 Million | $78.33 Million | 9.45x | 57.42x |
Competitor Companies of CLBT by Market Capitalization
Companies near Cellebrite DI in the global market cap rankings as of May 3, 2026.
Key companies related to Cellebrite DI by market ranking:
- Microsoft Corporation (NASDAQ:MSFT): Ranked #3 globally with a market cap of $2.78 Trillion USD.
- Oracle Corporation (NYSE:ORCL): Ranked #32 globally with a market cap of $429.39 Billion USD.
- Palantir Technologies Inc. (NASDAQ:PLTR): Ranked #42 globally with a market cap of $330.13 Billion USD.
- Palantir Technologies Inc. Class A Common Stock (NYSE:PLTR): Ranked #43 globally with a market cap of $324.25 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3 | Microsoft Corporation | NASDAQ:MSFT | $2.78 Trillion | $414.44 |
| #32 | Oracle Corporation | NYSE:ORCL | $429.39 Billion | $171.83 |
| #42 | Palantir Technologies Inc. | NASDAQ:PLTR | $330.13 Billion | $144.07 |
| #43 | Palantir Technologies Inc. Class A Common Stock | NYSE:PLTR | $324.25 Billion | $178.15 |
Cellebrite DI Historical Marketcap From 2020 to 2026
Between 2020 and today, Cellebrite DI's market cap moved from $2.63 Billion to $ 3.33 Billion, with a yearly change of 6.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.33 Billion | -25.96% |
| 2025 | $4.50 Billion | -18.16% |
| 2024 | $5.50 Billion | +154.39% |
| 2023 | $2.16 Billion | +98.62% |
| 2022 | $1.09 Billion | -45.64% |
| 2021 | $2.00 Billion | -23.84% |
| 2020 | $2.63 Billion | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Cellebrite DI was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.10 Billion USD |
| MoneyControl | $3.10 Billion USD |
| MarketWatch | $3.10 Billion USD |
| marketcap.company | $3.10 Billion USD |
| Reuters | $3.10 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cellebrite DI
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more